Pricing Log in Create free account

Enveric Biosciences, Inc. (ENVB) vs Synlogic, Inc. (SYBX)

Enveric Biosciences, Inc. and Synlogic, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Synlogic, Inc. are of similar size ($6.7M and $6.3M). Synlogic, Inc. grew revenue faster over the last twelve months: 188.7% against −13.9%. Across the 12 metrics below, Synlogic, Inc. leads on 7 and Enveric Biosciences, Inc. on 5.

Valuation

Metric ENVB SYBX Biotechnology median
P/E n/m n/m 10.60
P/S 0.16 4.26 9.40
P/B 0.70 1.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.27 n/m 0.66
EV/Sales (0.07) 0.15 9.02
Earnings yield (1,322.27%) (5.45%) (32.88%)
Free cash flow yield (188.36%) (26.92%) (23.13%)

Profitability

Metric ENVB SYBX Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (235.48%) (5.32%) (51.96%)
Return on assets (193.53%) (4.25%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENVB SYBX Biotechnology median
Revenue growth (TTM) (13.93%) 188.74% 6.76%
EPS growth (last fiscal year) 84.14% 95.83% 29.88%
Revenue growth, 5-year CAGR — (67.55%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENVB SYBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.21 9.19 4.97
Net debt to EBITDA 0.55 3.66 1.01

Dividend

Metric ENVB SYBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENVB SYBX Biotechnology median
Market cap 6.26m 6.68m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack